NCT07243704From ClinicalTrials.govRecruiting

Reducing the Burden of Cardiovascular Events With Antiplatelet Therapy in Patients With IntraCerebral Haemorrhage

Reducing the Burden of Cardiovascular Events With Antiplatelet Therapy in Patients With IntraCerebral Haemorrhage.

Intracerebral Haemorrhage

At a glance

Phase: Phase 3
Study type: Interventional
Sponsor: Christian Medical College and Hospital, Ludhiana, India
Enrolment target: 5,676
Started: 16 February 2026
Main results due: 15 February 2029
Study sites: 33
Registry updated: 24 September 2026

Can you take part?

Ages 18 years to 99 years.
Open to any sex.
You need the condition being studied — healthy volunteers are not accepted.

These are the headline rules only. Every study has a longer list, and whether you are eligible is decided by the research team at the site — never by this page.

Read the full eligibility criteria

Inclusion Criteria:

* Age ≥18 years
* First-ever Intracerebral Haemorrhage
* Presenting ≥24 hrs up to 3 months of stroke symptoms confirmed by brain imaging
* CT /MRI confirming Intracerebral Haemorrhage
* Alive ≥24 hours after non-traumatic ICH

Exclusion Criteria:

* ICH is known to be due to trauma, a structural cause (e.g., aneurysm, arteriovenous malformation, cerebral cavernous malformation, venous thrombosis, or tumour), or haemorrhagic transformation of cerebral infarction
* Glasgow coma score ≤5
* Taking any antiplatelet or anticoagulant therapy 15 days prior to randomization.
* Women pregnant, breastfeeding, childbearing potential, and not using contraceptives
* Enrolled in any other clinical trial
* Sick or compromised patients with life expectancy of less than a year
* Geographical or other factors that prohibit long-term follow-up

What this study is about

In the sponsor’s own words, from the registry.

BEAT ICH will be a pragmatic, randomised, placebo-controlled, blinded, superiority clinical trial aiming to recruit 5676 patients aged ≥18 years who survive ICH and assign them 1:1 to starting antiplatelet monotherapy (Aspirin 75 mg od) versus placebo for the entire duration of the trial for preventing MACE. Recruitment duration is for 2.5 years. The duration of the medication and follow-up will vary based on recruitment timeline. If recruited during the first year of the trial, the patient will take the medication for three years or until the trial ends or an event occurs, with a matching follow-up period. If recruited towards the end of the trial, he/she will take the medication for six months and be followed up for the same duration. The trial's follow-up duration is three years. The patients will be recruited for 2.5 years, and the last recruit will have a minimum follow-up of six months. No new patients will be recruited within the last six months of the trial, but all the patients will be followed up until the end of the trial.

Study sites(33)

Government General Hospital
Guntur, Andhra Pradesh, India
Recruiting
Lalitha Super Specialty Hospital
Guntur, Andhra Pradesh, India
Recruiting
Dr Ramesh Cardiac and Multispecialty Hospital
Guntur, Andhra Pradesh, India
Recruiting
Government General Hospital
Kākināda, Andhra Pradesh, India
Recruiting
Narayana Medical College and Hospital
Nellore, Andhra Pradesh, India
Recruiting
Apollo Excelcare Hospitals
Guwahati, Assam, India
Recruiting
Baptist Christian Hospital
Tezpur, Assam, India
Recruiting
All India Institute of Medical Science
Patna, Bihar, India
Recruiting
Rajendra Institute of Medical Sciences
Ranchi, Jharkhand, India
Recruiting
KLE's Dr. Prabhakar Kore Hospital & Medical Research Centre
Belagavi, Karnataka, India
Recruiting
Amrita Institute for Medical Sciences and Research Center
Kochi, Kerala, India
Recruiting
Government Medical College Trivandrum
Thiruvananthapuram, Kerala, India
Recruiting
Sree Chitra Tirunal Institute for Medical Sciences and Technology
Thiruvananthapuram, Kerala, India
Recruiting
P. D. Hinduja Hospital and Medical Research Centre
Mumbai, Maharashtra, India
Recruiting
Bharati Vidyapeeth DTU Medical College
Pune, Maharashtra, India
Recruiting
Institute of Human Behaviour and Allied Sciences
New Delhi, National Capital Territory of Delhi, India
Recruiting
All India Institute of Medical Sciences
Bhubaneswar, Odisha, India
Recruiting
Guru Gobind Singh Medical College and Hospital
Farīdkot, Punjab, India
Recruiting
PBM Hospital
Bikaner, Rajasthan, India
Recruiting
Santokba Durlabhji Memorial Hospital
Jaipur, Rajasthan, India
Recruiting
Jaiswal Hospital and Neuro Institute
Kota, Rajasthan, India
Recruiting
KG Hospital and Post Graduate Medical Institute Coimbatore
Coimbatore, Tamil Nadu, India
Recruiting
Christian Medical College Vellore
Vellore, Tamil Nadu, India
Recruiting
King George's Medical University
Lucknow, Uttar Pradesh, India
Recruiting
All India Institute of Medical Sciences
Raebareli, Uttar Pradesh, India
Recruiting
Institute of Medical Sciences of the Banaras Hindu University (BHU)
Varanasi, Uttar Pradesh, India
Recruiting
Bangur Institute of Neurosciences
Kolkata, West Bengal, India
Recruiting
St Stephen's Hospital
Delhi, India
Recruiting
All India Institute of Medical Science
Guwahati, India
Recruiting
KIMS-Sunshine Hospitals
Hyderabad, India
Recruiting
Renova Institute of Neurological Sciences (RINS); Renova Century Hospital
Hyderabad, India
Recruiting
Sanjay Gandhi Postgraduate Institute of Medical Sciences
Lucknow, India
Recruiting
All India Institute of Medical Science
New Delhi, India
Recruiting

Showing 33 of 33 sites. 33 of the 33 sites on this study are recruiting right now — a site can stop enrolling while the study as a whole is still open.

Source: ClinicalTrials.gov record NCT07243704. Trialion does not run this study, is not paid to refer anyone to it, and cannot enrol you. Eligibility is always decided by the research team at the site.

Not the right study?

Answer three questions and see the studies recruiting near you, in plain language.

Find a study for me